High-risk human papillomavirus (HPV) E6 proteins associate with the cellular 25 ubiquitin ligase E6-Associated Protein (E6AP), and then recruit both p53 and certain 26 cellular PDZ proteins for ubiquitination and degradation by the proteasome. Low-risk 27 HPV E6 proteins also associate with E6AP, yet fail to recruit p53 or PDZ proteins; their 28 E6AP-dependent targets have so far been uncharacterized. We found a cellular PDZ 29 protein called Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) is targeted for 30 degradation by both high and low-risk HPV E6 proteins as well as E6 proteins from 31 diverse non-primate mammalian species. NHERF1 was degraded by E6 in a manner 32 dependent upon E6AP ubiquitin ligase activity but independent of PDZ interactions. A 33 novel structural domain of E6, independent of the p53 recognition domain, was 34 necessary to associate with and degrade NHERF1, and the NHERF1 EB domain was 35 required for E6-mediated degradation. Degradation of NHERF1 by E6 activated 36 canonical Wnt/-catenin signaling, a key pathway that regulates cell growth and 37 proliferation. Expression levels of NHERF1 increased with increasing cell confluency. 38
Introduction 70
Human papillomaviruses (HPVs) are small DNA tumor viruses that cause 71 squamous epithelial papillomas in which the virus replicates. The papillomas are initially 72 benign and the host is usually able to clear the underlying HPV infection over time. 73
However, a subset of HPV infections may result in lesions that persist and grow to 74 harmful size or that have a propensity to evolve into carcinomas [1] . The cancer-causing 75 HPV types are called high-risk and the most commonly occurring high-risk types are 76 HPV16 and HPV18. Worldwide, high-risk HPVs are responsible for 5% of cancers, with 77 cervical cancer being the most common [2] . HPV types that are not associated with 78 malignancies are termed low-risk HPV; although low-risk for malignancies, the size and 79 location of the benign papillomas can render these lesions medically serious [3] . 80
Beyond HPVs, papillomaviruses have been isolated from mammalian species 81 including rodents, primates, bats, cetaceans, and ungulates [4] , and are clustered into 82 related genera based upon the divergence of the L1 capsid protein nucleotide sequence 83 (both high and low-risk mucosal HPV types discussed in this study belong to the 84 primate Alpha genera) [5] . Most non-human papillomaviruses encode E6 proteins that 85 are similar in predicted fold to high-risk HPV16 E6 [6] . When diverse mammalian 86 papillomaviruses are clustered based on their E6 sequence similarity, two main groups 87 of papillomaviruses emerge: those that encode E6 proteins that bind to the Notch co-88 activator Mastermind Like 1 (MAML1), and those that bind to a cellular E3 ubiquitin 89 ligase called E6-Associated Protein (E6AP) [7] . An E6 protein that preferentially binds 90 MAML1 suppresses MAML1 transcriptional activation, while an E6 protein that 91 preferentially binds E6AP stimulates E6AP E3 ubiquitin ligase activity to then target 92 7 reduction of NHERF1 protein levels by 16E6, 18E6, and 11E6. In order to characterize 139 the reduction of NHERF1 by these E6 proteins, we performed transient transfections 140
into E6AP-null 8B9 cells reconstituted with either WT E6AP (E6AP_WT) or a mutant 141 E6AP defective in ubiquitin ligase activity (E6AP_Ub -). E6APs were co-transfected with 142 plasmids encoding p53, NHERF1, and 16E6, 16E6 deleted of the PBM (16E6∆PBM), 143 11E6, or 18E6. Consistent with published literature, p53 was degraded by high-risk E6 144 proteins (16E6 and 18E6) independently of a PBM [25] and dependent upon E6AP 145 ubiquitin ligase activity [28] (Fig 1) . Expression of 11E6 together with E6AP_WT 146 resulted in a lack of p53 degradation by low-risk E6 (11E6), corroborating published 147 findings [17, 29] . However, NHERF1 protein levels were reduced by each observed E6 148 protein ( Fig 1A) , in contrast to what has been previously published [26] . 149
To ensure the reduction of NHERF1 by either high or low-risk E6 proteins was 150 not due to an overexpression artifact, we performed an E6 titration experiment ( Fig 1B) . 151
Representative western blots from which the quantification in Fig 1B was We established that NHERF1 protein levels are reduced by E6 in a transient 164 transfection system. To determine whether low levels of stable 16E6-expression could 165 initiate the reduction of NHERF1 protein levels, we retrovirally transduced normal 166 immortalized keratinocytes with either empty vector or 16E6_WT and observed 167 NHERF1 protein levels. Initially, our results were variable. We hypothesized that 168 keratinocyte confluency may affect NHERF1 protein levels. To test this possibility, we 169 seeded vector-transduced and 16E6_WT-transduced keratinocytes at three different 170 cell densities: 5x10 3 cells/cm 2 (very sub-confluent), 1.3x10 4 cells/cm 2 (sub-confluent), 171 and 2.6x10 4 cells/cm 2 (mid-confluent). NHERF1 protein levels increased with an 172 increase in cell density and 16E6_WT consistently reduced NHERF1 (Fig 2A) . In order 173 to determine if changes in NHERF1 levels with confluency were secondary to changes 174 in NHERF1 RNA levels, we performed qPCR on RNA extracted from keratinocytes 175 retrovirally transduced with vector or 16E6_WT and plated as in Fig 2A. Interestingly, 176 NHERF1 RNA levels did not differ between keratinocytes seeded at different densities 177 expressing either empty vector or 16E6_WT ( Fig 2B) . 178
E6-mediated degradation of NHERF1 occurs via the proteasome. 179
Because the ability of each E6 protein to reduce NHERF1 protein levels was also 180 dependent upon the ubiquitin ligase activity of E6AP ( Fig 1A) , we hypothesized that E6 181 reduction of NHERF1 levels would be secondary to proteasome activity. We seeded 182 retrovirally transduced keratinocytes expressing either empty vector or 16E6_WT at 183 similar confluency and treated with either DMSO, mitomycin C (MMC) to induce p53 184
[30], or the proteasome inhibitor MG132 at differing concentrations for 8 hours. As 185 expected, p53 levels increased in vector keratinocytes treated with MMC compared to 186 untreated cells as well as in 16E6_WT cells exposed to increasing concentrations of 187 MG132 [28] (Fig 3) . NHERF1 protein levels increased significantly in a dose dependent 188 manner upon treatment with MG132 in parallel to that seen with p53. (Fig 3, lanes 3-8) . 189
This indicated that NHERF1 is degraded through the proteasome by E6 in a manner 190 dependent upon WT E6AP. 191
E6-mediated degradation of NHERF1 is conserved across papillomaviruses from 192 diverse hosts. 193
The observation that NHERF1 was targeted by both high and low-risk HPV E6 194 proteins suggested that NHERF1 may also be a target of diverse non-primate E6 195 proteins. We examined the ability of E6 proteins from multiple different genera and 196 different mammalian species to target NHERF1 for degradation ( Fig 4) . E6 proteins that 197 preferentially bind MAML1 were unable to degrade NHERF1 ( Fig 4A and 4B) . All of the 198 tested Alpha (primate), Dyodelta (boar), and Dyopi (porpoise) genera E6 proteins that 199 bind E6AP targeted NHERF1. While E6AP-binding was necessary it was not sufficient, 200 as E6 proteins from Omega (polar bear, UmPV1) and Omikron (cetaceans, PphPV1 201 and TtPV5) did not degrade NHERF1 ( Fig 4A) . Interestingly, E6 proteins that bind E6AP 202 but did not target NHERF1 degradation sequence-clustered separately from E6 proteins 203 that did target NHERF1 degradation, suggesting evolutionary divergence of this function 204 ( Fig 4B) . 205
A novel 16E6 substrate interaction domain is required for 16E6 degradation of 206

NHERF1. 207
Because the ability of E6 to degrade NHERF1 was not dependent upon the 208 presence of a PBM (Figs 1 and 4) , we attempted to identify which residue(s) of 16E6 209 were required to mediate degradation of NHERF1. The crystal structure of 16E6 210 complexed with the E6-binding peptide from E6AP [31] ( Fig 6A) was examined to 211 identify amino acids that were at least 20% exposed, resulting in over eighty candidate 212 residues (S2 Fig) . Candidate residues were individually mutated in the context of the 213 16E6 gene and the resulting point mutants were screened for their ability to degrade 214 NHERF1 in the presence of E6AP_WT in transiently transfected C33 cells. To ensure 215 our point mutants were not functionally defective (i.e. could not fold properly or could not 216 interact with E6AP), we also screened the mutants for ability to degrade p53. A 217 selection of mutants and the results of the screen are shown in Fig 5. Four mutants 218 stood out as selectively defective in their ability to degrade NHERF1 ( Fig 5B) while still 219 being able to degrade p53 ( Fig 5C) : F69A, K72A, F69R and a double mutant: 220 F69A/K72A. As evidenced in the crystal structure of 16E6, the side chains of F69 and 221 K72 ( Fig 6B) are located along the connecting alpha-helix that links the amino-terminal 222 and carboxy-terminal zinc-structured domains of 16E6. The F69 and K72 side chains 223 are aligned and adjacent on the connecting helix, which is on the opposite side of 16E6 224 from the p53 interaction surface [32] ( Fig 6C) . 
Degradation of NHERF1 by 16E6 requires the NHERF1 EB domain. 235
Because the PBM of E6 proteins is not required to initiate the degradation of 236 NHERF1 (Figs 1, 4, and 7), we hypothesized that neither of the PDZ domains of 237 NHERF1 would be required for 16E6 to initiate NHERF1 degradation. We truncated 238 NHERF1 and deleted several characterized domains within the protein [33, 34] ( Fig 8A) . 239 E6AP-null 8B9 cells were co-transfected with 16E6_WT, NHERF1 truncations, 240 HA_GFP, and either E6AP_Ubor E6AP_WT. NHERF1 protein levels were quantified, 241
and then normalized to the internal transfection control (HA_GFP). The various 242 NHERF1 truncations displayed different expression levels. To account for these 243 variations, levels of NHERF1 truncations in the presence of E6AP_Ubwere set to 244 100% and the expression level of the corresponding NHERF1 truncation in the 245 presence of E6AP_WT was normalized accordingly ( Fig 8B and 8C , bar graphs). All 246 NHERF1 truncations containing the EB domain were targeted for degradation by 16E6 247 in the presence of E6AP_WT (highlighted in green in Fig 8A) . Truncations of NHERF1 248 that lacked the EB domain were not targeted for degradation by 16E6 (highlighted in red 249 in Fig 8A) . In addition, the NHERF1 PBM was not required for 16E6 mediated 250 degradation ( Fig 8C, lanes 5 vs. 6 and 9 vs. 10). 251
We identified the NHERF1 EB domain as a requirement for 16E6 mediated 252 degradation and the importance of 16E6 residues F69 and K72. In order to examine the 253 interactions between the 16E6+E6AP+NHERF1 complex, all three proteins were 254 expressed in a yeast three-hybrid system so as to detect the heterotrimeric complex. 255
We fused 16E6_WT and ubiquitin ligase dead E6AP (E6AP_Ub -) to the LexA DNA 256 binding domain and co-expressed this fusion with either vector, 16E6_WT, or 257 16E6_F69A/K72A in yeast containing a LexA responsive LacZ reporter. These yeast 258
were then mated to yeast expressing native p53 or Gal4 (G4) transactivator fusions to 259 NHERF1 121-358 (containing the EB domain), NHERF1 121-297 (deleted of the EB 260 domain), 16E6_WT, or the tyrosine phosphatase PTPN3 (a PDZ protein) ( Fig 9) . The 261
LexA_16E6 fusion co-expressed with p53 (in the absence of E6AP) resulted in very 262 weak activation of the LacZ reporter (spot 4B) while co-expression with G4_PTPN3 263 resulted in strong transactivation (spot 6B), but no interaction with NHERF1 (spots 2B 264 and 3B). We then co-expressed 16E6 and E6AP by using a LexA_E6AP_Ubfusion 265 together with native 16E6. When LexA_E6AP_Ub -, untagged 16E6_WT, and p53 were 266 co-expressed, a strong activation of the LacZ reporter was observed (Fig 9, spot 4D) , 267 illustrating that while p53 has a weak direct interaction with 16E6, it interacts strongly 268 with 16E6 bound to E6AP. This activation was also seen with 16E6_F69A/K72A in the 269 presence of LexA_E6AP_Uband p53 (Fig 9, spot 4E papillomaviruses from multiple divergent mammalian species. The ability of these E6s 307 to degrade NHERF1 is dependent upon E6AP (Fig 1) and the proteasome (Fig 3) . In 308 addition, we identify two amino acids in 16E6 (F69 and K72) that are necessary for E6-309 mediated degradation of NHERF1. These two residues are aligned, and adjacent in the 310 outwardly oriented face of the E6 connecting alpha helix, suggesting a novel interaction 311 domain ( Fig 6B and 6C) . NHERF1 degradation by E6 requires the NHERF1 EB domain, 312 but does not require the PBM at the extreme carboxy terminus of NHERF1 ( Fig 8B and  313   8C ). The ability of E6 proteins to degrade NHERF1 augments the canonical Wnt/-314 catenin signaling (Fig 10) , an oncogenic pathway frequently active in cancer. 315 NHERF1 is the product of the SLC9A3R1 gene. SLC9A3R1 mRNA is broadly 316 expressed in epithelia, with the highest mRNA expression in kidney, gut, and 317 esophagus. NHERF1 is not developmentally essential, although mice have considerably 318 The EB domain of NHERF1 is required for E6-mediated degradation in the 352 presence of E6AP (Fig 8B and 8C) . This domain is responsible for linking NHERF1 to 353 the actin cytoskeleton network via interaction with ERM proteins [48] . NHERF1 has a 354 PBM at its extreme carboxy terminus and when the EB domain is not bound to ERM 355 proteins, the NHERF1 PBM can self-associate with the NHERF1 PDZ2 domain, 356 resulting in a closed NHERF1 conformation [33] . The head-to-tail closed NHERF1 357 confirmation is not required for E6-mediated degradation, as an NHERF1∆PBM mutant 358 was still targeted for degradation by E6 in the presence of E6AP_WT ( Fig 8C) . Nor was 359 the 16E6 PBM required for degradation of NHERF1 (Figs 1, 4, and 7) , contrary to a 360 prior report [26] . 361
In addition to the requirement of the NHERF1 EB domain, two E6 residues, F69 362 and K72, are necessary for E6-mediated NHERF1 degradation (Figs 5 and 7) . Crucially, 363 the 16E6_F69A/K72A double mutant can still initiate the degradation of p53, indicating it 364 is still able to bind E6AP, recruit p53 to the complex, and trigger ubiquitination. The F69 365 and K72 residues are also required to form a tri-molecular complex between E6AP, E6, 366 and NHERF1 in yeast (Fig 9, spot 2E vs. 2D). Like the association of E6 with p53, 367 NHERF1 does not interact directly with E6, but requires prior association of E6 with 368 E6AP, indicating that NHERF1 requires an altered conformation of E6 that is secondary 369 to E6 binding to E6AP [58] . 370
As we were testing the ability of E6 proteins to degrade NHERF1 in stable 371 keratinocyte cell lines, we discovered that NHERF1 protein levels are sensitive to cell 372 confluency (Fig 2A) . The relationship between NHERF1 and cell confluency may 373 contribute to the lack of identification of NHERF1 as a degradation target of low-risk E6 374 proteins in the past, as well as differences between our studies and a prior publication 375
[26]. It is likely that this observation underlies disparate findings between different 376 laboratories regarding NHERF1 cancer associated traits [49, 50] . Future studies of 377 NHERF1 must take into account and carefully control cell densities when performing 378
experiments. 379
Binding to E6AP is necessary for E6-induced degradation of NHERF1, but it is 380 not sufficient, as three tested E6 proteins that bind E6AP do not target NHERF1 for 381 degradation: UmPV1 E6 (polar bear), PphPV1 E6 (porpoise), and TtPV5 E6 (bottlenose 382 dolphin) ( Fig 4A) . Interestingly, the three E6 proteins that do not degrade NHERF1 383 cluster together in phylogenetic relatedness ( Fig 4B) . We utilized transfected human 384 NHERF1 throughout our study, so it is possible that the inability of these three E6 385 proteins to target NHERF1 for degradation may be due to evolutionary divergence in the 386 NHERF1 homologs. Future studies will explore if the lack of degradation of human 387 NHERF1 by UmPV1, PphPV1, and TtPV5 is due to evolutionary divergence of the 388 respective NHERF1 proteins compared to human NHERF1. It would be of interest to 389 determine if NHERF1 is a "universal" target of E6 proteins that act through association 390 with E6AP. 
RT-PCR 426
Retrovirally transduced NIKS were plated at different cell densities and harvested 427 following a TRIzol RNA harvest protocol (Invitrogen). cDNA was generated using 428 random hexamers. Quantitative real-time PCR was performed on the cDNA using iQ TM 429 SYBR® Green Supermix (BioRad #1708880). The primers targeted the SLC9A3R1 430 gene (BioRad Assay ID: qHsaCEP0050521) and the GAPDH gene (BioRad Assay ID: conditioned media was generated using L Wnt-3A murine fibroblasts (ATCC, CRL-444 2647) as previously described [63] . 445
Phylogenetic analysis 446
Multiple protein sequence files were downloaded from the Papillomavirus Episteme [64] 447 and aligned using the EMBL-EBI MUSCLE (MUltiple Sequence Comparison by Log-448 Expectation) program [65]. The phylogenetic tree was generated as a neighbour-joining 449 tree without distance corrections within the MUSCLE program [65] . 450
Yeast expression 451
Modified LexA-based yeast three-hybrid assays were performed as previously 452 E6AP_Ubwere co-expressed in yeast (bait) together with either vector, 16E6_WT, or 766 16E6_F69A/K72A as indicated. The bait yeast were mated to prey yeast expressing 767
Gal4 activation domain (G4), or G4 fused to 16E6_WT, PTPN3, truncations of NHERF1, 768 or native p53 and diploids selected. Positive controls for 16E6 expression included the 769
